Amsterdam Public Health
-
Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine
Kooij, K. W., Wit, F. W. N. M., van Zoest, R. A., Schouten, J., Kootstra, N. A., van Vugt, M., Prins, M., Reiss, P. & van der Valk, M., 2016, In: AIDS (London, England). 30, 11, p. 1771-1780Research output: Contribution to journal › Article › Academic › peer-review
-
Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection
van der Valk, M., Zaaijer, H. L., Kater, A. P. & Schinkel, J., 2017, In: Journal of Hepatology. 66, 1, p. 242-243Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life
Willemse, S. B., Baak, L. C., Kuiken, S. D., van der Sluys Veer, A., Lettinga, K. D., van der Meer, J. T. M., Depla, A. C. T. M., Tuynman, H., van Nieuwkerk, C. M. J., Schinkel, C. J., Kwa, D., Reesink, H. W. & van der Valk, M., Dec 2016, In: Journal of viral hepatitis. 23, 12, p. 950-954 5 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
-
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019
Requena, M-B., Protopopescu, C., Stewart, A. C., van Santen, D. K., Klein, M. B., Jarrin, I., Berenguer, J., Wittkop, L., Salmon, D., Rauch, A., Prins, M., van der Valk, M., Sacks-Davis, R., Hellard, M. E., Carrieri, P. & InCHEHC Collaboration, 1 Feb 2024, In: International Journal of Drug Policy. 124, 104311.Research output: Contribution to journal › Article › Academic › peer-review
-
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies
InCHEHC Collaboration, 12 Jan 2024, (E-pub ahead of print) In: Lancet HIV.Research output: Contribution to journal › Article › Academic › peer-review
-
Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis
van Welzen, B. J., Van Lelyveld, S. F. L., Ter Beest, G., Gisolf, J. H., Geerlings, S. E., Prins, J. M., Van Twillert, G., Van Nieuwkoop, C., Van der Valk, M., Burger, D. & Wensing, A. M. J., 11 Jan 2024, (E-pub ahead of print) In: Clinical Infectious Diseases.Research output: Contribution to journal › Article › Academic › peer-review
- All publications